Metformin ameliorates the severity of experimental Alport syndrome

Metformin is widely used for the treatment of type 2 diabetes, and increasing numbers of studies have shown that metformin also ameliorates tumor progression, inflammatory disease, and fibrosis. However, the ability of metformin to improve non-diabetic glomerular disease and chronic kidney disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Omachi, Kohei, Kaseda, Shota, Yokota, Tsubasa, Kamura, Misato, Teramoto, Keisuke, Kuwazuru, Jun, Kojima, Haruka, Nohara, Hirofumi, Koyama, Kosuke, Ohtsuki, Sumio, Misumi, Shogo, Takeo, Toru, Nakagata, Naomi, Li, Jian-Dong, Shuto, Tsuyoshi, Suico, Mary Ann, Miner, Jeffrey H., Kai, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007696/
https://www.ncbi.nlm.nih.gov/pubmed/33782421
http://dx.doi.org/10.1038/s41598-021-86109-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007696/
https://www.ncbi.nlm.nih.gov/pubmed/33782421
http://dx.doi.org/10.1038/s41598-021-86109-1

Ejemplares similares